---
document_datetime: 2023-09-21 17:53:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/topotecan-teva-epar-all-authorised-presentations_en.pdf
document_name: topotecan-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9559465
conversion_datetime: 2025-12-20 09:44:23.522979
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name           | Strength   | Pharmaceutical Form                   | Route of Administration   | Packaging    | Content (concentration)   | Package size   |
|-----------------|----------------|------------|---------------------------------------|---------------------------|--------------|---------------------------|----------------|
| EU/1/09/552/001 | Topotecan Teva | 1 mg/1 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 1 ml (1mg/ml)             | 1 vial         |
| EU/1/09/552/002 | Topotecan Teva | 1 mg/1 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 1 ml (1mg/ml)             | 5 vials        |
| EU/1/09/552/003 | Topotecan Teva | 4 mg/4 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 4 ml (1mg/ml)             | 1 vial         |
| EU/1/09/552/004 | Topotecan Teva | 4 mg/4 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 4 ml (1mg/ml)             | 5 vials        |